Nature Reviews Endocrinology / Jan 06, 2015

Grayson, W. L., Bunnell, B. A., Martin, E., Frazier, T., Hung, B. P., & Gimble, J. M. (2015). Stromal cells and stem cells in clinical bone regeneration. Nature Reviews Endocrinology, 11(3), 140–150. https://doi.org/10.1038/nrendo.2014.234

PLoS ONE / Mar 05, 2012

Tilghman, S. L., Bratton, M. R., Segar, H. C., Martin, E. C., Rhodes, L. V., Li, M., McLachlan, J. A., Wiese, T. E., Nephew, K. P., & Burow, M. E. (2012). Endocrine Disruptor Regulation of MicroRNA Expression in Breast Carcinoma Cells. PLoS ONE, 7(3), e32754. https://doi.org/10.1371/journal.pone.0032754

Breast Cancer Research / Mar 14, 2012

Zhou, C., Zhong, Q., Rhodes, L. V., Townley, I., Bratton, M. R., Zhang, Q., Martin, E. C., Elliott, S., Collins-Burow, B. M., Burow, M. E., & Wang, G. (2012). Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration. Breast Cancer Research, 14(2). https://doi.org/10.1186/bcr3144

Oncotarget / Mar 21, 2015

Rhodes, L. V., Martin, E. C., Segar, H. C., Miller, D. F. B., Buechlein, A., Rusch, D. B., Nephew, K. P., Burow, M. E., & Collins-Burow, B. M. (2015). Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer. Oncotarget, 6(18), 16638–16652. https://doi.org/10.18632/oncotarget.3184

Frontiers in Bioengineering and Biotechnology / May 24, 2018

Belgodere, J. A., King, C. T., Bursavich, J. B., Burow, M. E., Martin, E. C., & Jung, J. P. (2018). Engineering Breast Cancer Microenvironments and 3D Bioprinting. Frontiers in Bioengineering and Biotechnology, 6. https://doi.org/10.3389/fbioe.2018.00066

Oncology Reports / Oct 04, 2011

Collins-Burow, B. (2011). The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells. Oncology Reports. https://doi.org/10.3892/or.2011.1488

Biochimie / May 01, 2016

Martin, E. C., Qureshi, A. T., Dasa, V., Freitas, M. A., Gimble, J. M., & Davis, T. A. (2016). MicroRNA regulation of stem cell differentiation and diseases of the bone and adipose tissue: Perspectives on miRNA biogenesis and cellular transcriptome. Biochimie, 124, 98–111. https://doi.org/10.1016/j.biochi.2015.02.012

Molecular Carcinogenesis / Aug 21, 2012

Martin, E. C., Elliott, S., Rhodes, L. V., Antoon, J. W., Fewell, C., Zhu, Y., Driver, J. L., Jodari‐Karimi, M., Taylor, C. W., Flemington, E. K., Beckman, B. S., Collins‐Burow, B. M., & Burow, M. E. (2012). Preferential star strand biogenesis of pre‐miR‐24‐2 targets PKC‐alpha and suppresses cell survival in MCF‐7 breast cancer cells. Molecular Carcinogenesis, 53(1), 38–48. Portico. https://doi.org/10.1002/mc.21946

Molecular and Cellular Endocrinology / Dec 01, 2017

Burks, H., Pashos, N., Martin, E., Mclachlan, J., Bunnell, B., & Burow, M. (2017). Endocrine disruptors and the tumor microenvironment: A new paradigm in breast cancer biology. Molecular and Cellular Endocrinology, 457, 13–19. https://doi.org/10.1016/j.mce.2016.12.010

PLoS ONE / Aug 09, 2013

Antoon, J. W., Martin, E. C., Lai, R., Salvo, V. A., Tang, Y., Nitzchke, A. M., Elliott, S., Nam, S. Y., Xiong, W., Rhodes, L. V., Collins-Burow, B., David, O., Wang, G., Shan, B., Beckman, B. S., Nephew, K. P., & Burow, M. E. (2013). MEK5/ERK5 Signaling Suppresses Estrogen Receptor Expression and Promotes Hormone-Independent Tumorigenesis. PLoS ONE, 8(8), e69291. https://doi.org/10.1371/journal.pone.0069291

Oncogenesis / Oct 05, 2015

Rhodes, L. V., Tate, C. R., Hoang, V. T., Burks, H. E., Gilliam, D., Martin, E. C., Elliott, S., Miller, D. B., Buechlein, A., Rusch, D., Tang, H., Nephew, K. P., Burow, M. E., & Collins-Burow, B. M. (2015). Regulation of triple-negative breast cancer cell metastasis by the tumor-suppressor liver kinase B1. Oncogenesis, 4(10), e168–e168. https://doi.org/10.1038/oncsis.2015.27

FEBS Letters / Jan 01, 2017

Martin, E. C., Conger, A. K., Yan, T. J., Hoang, V. T., Miller, D. F. B., Buechlein, A., Rusch, D. B., Nephew, K. P., Collins‐Burow, B. M., & Burow, M. E. (2017). MicroRNA‐335‐5p and ‐3p synergize to inhibit estrogen receptor alpha expression and promote tamoxifen resistance. FEBS Letters, 591(2), 382–392. Portico. https://doi.org/10.1002/1873-3468.12538

International Journal of Oncology / Feb 08, 2013

ANTOON, J. W., NITZCHKE, A. M., MARTIN, E. C., RHODES, L. V., NAM, S., WADSWORTH, S., SALVO, V. A., ELLIOTT, S., COLLINS-BUROW, B., NEPHEW, K. P., & BUROW, M. E. (2013). Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition. International Journal of Oncology, 42(4), 1139–1150. https://doi.org/10.3892/ijo.2013.1814

Journal of Biomedical Materials Research Part A / Sep 01, 2018

Thomas‐Porch, C., Li, J., Zanata, F., Martin, E. C., Pashos, N., Genemaras, K., Poche, J. N., Totaro, N. P., Bratton, M. R., Gaupp, D., Frazier, T., Wu, X., Ferreira, L. M., Tian, W., Wang, G., Bunnell, B. A., Flynn, L., Hayes, D., & Gimble, J. M. (2018). Comparative proteomic analyses of human adipose extracellular matrices decellularized using alternative procedures. Journal of Biomedical Materials Research Part A, 106(9), 2481–2493. Portico. https://doi.org/10.1002/jbm.a.36444

Scientific Reports / Aug 13, 2019

Shaik, S., Martin, E. C., Hayes, D. J., Gimble, J. M., & Devireddy, R. V. (2019). Transcriptomic Profiling of Adipose Derived Stem Cells Undergoing Osteogenesis by RNA-Seq. Scientific Reports, 9(1). https://doi.org/10.1038/s41598-019-48089-1

Scientific Reports / Jul 27, 2012

Antoon, J. W., Lai, R., Struckhoff, A. P., Nitschke, A. M., Elliott, S., Martin, E. C., Rhodes, L. V., Yoon, N. S., Salvo, V. A., Shan, B., Beckman, B. S., Nephew, K. P., & Burow, M. E. (2012). Altered Death Receptor Signaling Promotes Epithelial-to-Mesenchymal Transition and Acquired Chemoresistance. Scientific Reports, 2(1). https://doi.org/10.1038/srep00539

Molecular Cancer / Oct 06, 2014

Martin, E. C., Rhodes, L. V., Elliott, S., Krebs, A. E., Nephew, K. P., Flemington, E. K., Collins-Burow, B. M., & Burow, M. E. (2014). microRNA regulation of mammalian target of rapamycin expression and activity controls estrogen receptor function and RAD001 sensitivity. Molecular Cancer, 13(1). https://doi.org/10.1186/1476-4598-13-229

PLoS ONE / Nov 30, 2012

Martin, E. C., Bratton, M. R., Zhu, Y., Rhodes, L. V., Tilghman, S. L., Collins-Burow, B. M., & Burow, M. E. (2012). Insulin-Like Growth Factor-1 Signaling Regulates miRNA Expression in MCF-7 Breast Cancer Cell Line. PLoS ONE, 7(11), e49067. https://doi.org/10.1371/journal.pone.0049067

Genes & Cancer / Oct 01, 2014

Martin, E. C., Krebs, A. E., Burks, H. E., Elliott, S., Baddoo, M., Collins-Burow, B. M., Flemington, E. K., & Burow, M. E. (2014). miR-155 induced transcriptome changes in the MCF-7 breast cancer cell line leads to enhanced mitogen activated protein kinase signaling. Genes & Cancer, 5(9–10), 353–364. https://doi.org/10.18632/genesandcancer.33

Lab on a Chip / Jan 01, 2020

Rahman, S. M., Campbell, J. M., Coates, R. N., Render, K. M., Byrne, C. E., Martin, E. C., & Melvin, A. T. (2020). Evaluation of intercellular communication between breast cancer cells and adipose-derived stem cells via passive diffusion in a two-layer microfluidic device. Lab on a Chip, 20(11), 2009–2019. https://doi.org/10.1039/d0lc00142b

BMC Cancer / Mar 07, 2019

Matossian, M. D., Burks, H. E., Elliott, S., Hoang, V. T., Bowles, A. C., Sabol, R. A., Wahba, B., Anbalagan, M., Rowan, B., Abazeed, M. E., Bunnell, B. A., Moroz, K., Miele, L., Rhodes, L. V., Jones, S. D., Martin, E. C., Collins-Burow, B. M., & Burow, M. E. (2019). Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model. BMC Cancer, 19(1). https://doi.org/10.1186/s12885-019-5401-2

Breast Cancer Research and Treatment / Feb 01, 2018

Matossian, M. D., Burks, H. E., Bowles, A. C., Elliott, S., Hoang, V. T., Sabol, R. A., Pashos, N. C., O’Donnell, B., Miller, K. S., Wahba, B. M., Bunnell, B. A., Moroz, K., Zea, A. H., Jones, S. D., Ochoa, A. C., Al-Khami, A. A., Hossain, F., Riker, A. I., Rhodes, L. V., … Collins-Burow, B. M. (2018). A novel patient-derived xenograft model for claudin-low triple-negative breast cancer. Breast Cancer Research and Treatment, 169(2), 381–390. https://doi.org/10.1007/s10549-018-4685-2

Nanomedicine / Apr 01, 2020

Byrne, C. E., Astete, C. E., Vaithiyanathan, M., Melvin, A. T., Moradipour, M., Rankin, S. E., Knutson, B. L., Sabliov, C. M., & Martin, E. C. (2020). Lignin-graft-PLGA drug-delivery system improves efficacy of MEK1/2 inhibitors in triple-negative breast cancer cell line. Nanomedicine, 15(10), 981–1000. https://doi.org/10.2217/nnm-2020-0010

Oncoscience / Apr 29, 2018

Matossian, M. D., Burks, H. E., Elliott, S., Hoang, V. T., Bowles, A. C., Sabol, R. A., Bunnell, B. A., Martin, E. C., Burow, M. E., & Collins-Burow, B. M. (2018). Panobinostat suppresses the mesenchymal phenotype in a novel claudin-low triple negative patient-derived breast cancer model. Oncoscience, 5(3–4), 99–108. https://doi.org/10.18632/oncoscience.412

Cells Tissues Organs / Jan 01, 2016

Shah, F. S., Li, J., Zanata, F., Curley, J. L., Martin, E. C., Wu, X., Dietrich, M., Devireddy, R. V., Wade, J. W., & Gimble, J. M. (2016). The Relative Functionality of Freshly Isolated and Cryopreserved Human Adipose-Derived Stromal/Stem Cells. Cells Tissues Organs, 201(6), 436–444. Portico. https://doi.org/10.1159/000446494

The Journal of Steroid Biochemistry and Molecular Biology / Jun 01, 2015

Bratton, M. R., Martin, E. C., Elliott, S., Rhodes, L. V., Collins-Burow, B. M., McLachlan, J. A., Wiese, T. E., Boue, S. M., & Burow, M. E. (2015). Glyceollin, a novel regulator of mTOR/p70S6 in estrogen receptor positive breast cancer. The Journal of Steroid Biochemistry and Molecular Biology, 150, 17–23. https://doi.org/10.1016/j.jsbmb.2014.12.014

Tissue Engineering Part A / Apr 01, 2021

Byrne, C. E., Decombe, J.-B., Bingham, G. C., Remont, J., Miller, L. G., Khalif, L., King, C. T., Hamel, K., Bunnell, B. A., Burow, M. E., & Martin, E. C. (2021). Evaluation of Extracellular Matrix Composition to Improve Breast Cancer Modeling. Tissue Engineering Part A, 27(7–8), 500–511. https://doi.org/10.1089/ten.tea.2020.0364

Frontiers in Physiology / Nov 29, 2021

Brock, C. K., Hebert, K. L., Artiles, M., Wright, M. K., Cheng, T., Windsor, G. O., Nguyen, K., Alzoubi, M. S., Collins-Burow, B. M., Martin, E. C., Lau, F. H., Bunnell, B. A., & Burow, M. E. (2021). A Role for Adipocytes and Adipose Stem Cells in the Breast Tumor Microenvironment and Regenerative Medicine. Frontiers in Physiology, 12. https://doi.org/10.3389/fphys.2021.751239

PLOS ONE / Oct 09, 2020

Chang, T. C., Matossian, M. D., Elliott, S., Burks, H. E., Sabol, R. A., Ucar, D. A., Wathieu, H., Zabaleta, J., Valle, L. D., Gill, S., Martin, E., Riker, A. I., Miele, L., Bunnell, B. A., Burow, M. E., & Collins-Burow, B. M. (2020). Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor. PLOS ONE, 15(10), e0226464. https://doi.org/10.1371/journal.pone.0226464

Frontiers in Oncology / Aug 03, 2020

Hoang, V. T., Matossian, M. D., Ucar, D. A., Elliott, S., La, J., Wright, M. K., Burks, H. E., Perles, A., Hossain, F., King, C. T., Browning, V. E., Bursavich, J., Fang, F., Del Valle, L., Bhatt, A. B., Cavanaugh, J. E., Flaherty, P. T., Anbalagan, M., Rowan, B. G., … Burow, M. E. (2020). ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer. Frontiers in Oncology, 10. https://doi.org/10.3389/fonc.2020.01164

Non-Coding RNA / Sep 21, 2016

Conger, A., Martin, E., Yan, T., Rhodes, L., Hoang, V., La, J., Anbalagan, M., Burks, H., Rowan, B., Nephew, K., Collins-Burow, B., & Burow, M. (2016). Argonaute 2 Expression Correlates with a Luminal B Breast Cancer Subtype and Induces Estrogen Receptor Alpha Isoform Variation. Non-Coding RNA, 2(3), 8. https://doi.org/10.3390/ncrna2030008

Clinical and Translational Oncology / Aug 09, 2021

Matossian, M. D., Chang, T., Wright, M. K., Burks, H. E., Elliott, S., Sabol, R. A., Wathieu, H., Windsor, G. O., Alzoubi, M. S., King, C. T., Bursavich, J. B., Ham, A. M., Savoie, J. J., Nguyen, K., Baddoo, M., Flemington, E., Sirenko, O., Cromwell, E. F., Hebert, K. L., … Burow, M. E. (2021). In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types. Clinical and Translational Oncology, 24(1), 127–144. https://doi.org/10.1007/s12094-021-02677-8

Cancer and Metastasis Reviews / Aug 24, 2022

Bunnell, B. A., Martin, E. C., Matossian, M. D., Brock, C. K., Nguyen, K., Collins-Burow, B., & Burow, M. E. (2022). The effect of obesity on adipose-derived stromal cells and adipose tissue and their impact on cancer. Cancer and Metastasis Reviews, 41(3), 549–573. https://doi.org/10.1007/s10555-022-10063-1

Frontiers in Bioengineering and Biotechnology / Mar 15, 2021

Gurrala, R., Byrne, C. E., Brown, L. M., Tiongco, R. F. P., Matossian, M. D., Savoie, J. J., Collins-Burow, B. M., Burow, M. E., Martin, E. C., & Lau, F. H. (2021). Quantifying Breast Cancer-Driven Fiber Alignment and Collagen Deposition in Primary Human Breast Tissue. Frontiers in Bioengineering and Biotechnology, 9. https://doi.org/10.3389/fbioe.2021.618448

Journal of Cellular Physiology / Apr 10, 2018

Martin, E. C., Qureshi, A. T., Llamas, C. B., Boos, E. C., King, A. G., Krause, P. C., Lee, O. C., Dasa, V., Freitas, M. A., Forsberg, J. A., Elster, E. A., Davis, T. A., & Gimble, J. M. (2018). Trauma induced heterotopic ossification patient serum alters mitogen activated protein kinase signaling in adipose stem cells. Journal of Cellular Physiology, 233(9), 7035–7044. Portico. https://doi.org/10.1002/jcp.26504

Adipocyte / Feb 07, 2018

Martin, E. C., Qureshi, A. T., Llamas, C. B., Burow, M. E., King, A. G., Lee, O. C., Dasa, V., Freitas, M. A., Forsberg, J. A., Elster, E. A., Davis, T. A., & Gimble, J. M. (2018). Mirna biogenesis pathway is differentially regulated during adipose derived stromal/stem cell differentiation. Adipocyte, 1–10. https://doi.org/10.1080/21623945.2018.1423911

Annals of Oncology / Mar 01, 2012

Campone, M., Bondarenko, I., Brincat, S., Hotko, Y., Munster, P. N., Chmielowska, E., Fumoleau, P., Ward, R., Bardy-Bouxin, N., Leip, E., Turnbull, K., Zacharchuk, C., & Epstein, R. J. (2012). Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapy. Annals of Oncology, 23(3), 610–617. https://doi.org/10.1093/annonc/mdr261

Journal of Intellectual Disability Research / Nov 19, 2018

Ramsey, J., Martin, E. C., Purcell, O. M., Lee, K. M., & MacLean, A. G. (2018). Self‐injurious behaviours in rhesus macaques: Potential glial mechanisms. Journal of Intellectual Disability Research, 62(12), 1008–1017. Portico. https://doi.org/10.1111/jir.12558

ACS Biomaterials Science & Engineering / Aug 24, 2022

Khan, A. H., Zhou, S. P., Moe, M., Ortega Quesada, B. A., Bajgiran, K. R., Lassiter, H. R., Dorman, J. A., Martin, E. C., Pojman, J. A., & Melvin, A. T. (2022). Generation of 3D Spheroids Using a Thiol–Acrylate Hydrogel Scaffold to Study Endocrine Response in ER+ Breast Cancer. ACS Biomaterials Science & Engineering, 8(9), 3977–3985. https://doi.org/10.1021/acsbiomaterials.2c00491

Women's Health Reports / Apr 01, 2020

Matossian, M. D., Giardina, A. A., Wright, M. K., Elliott, S., Loch, M. M., Nguyen, K., Zea, A. H., Lau, F. H., Moroz, K., Riker, A. I., Jones, S. D., Martin, E. C., Bunnell, B. A., Miele, L., Collins-Burow, B. M., & Burow, M. E. (2020). Patient-Derived Xenografts as an Innovative Surrogate Tumor Model for the Investigation of Health Disparities in Triple Negative Breast Cancer. Women’s Health Reports, 1(1), 383–392. https://doi.org/10.1089/whr.2020.0037

Tissue Engineering Part A / Aug 01, 2020

Pashos, N. C., Graham, D. M., Burkett, B. J., O’Donnell, B., Sabol, R. A., Helm, J., Martin, E. C., Bowles, A. C., Heim, W. M., Caronna, V. C., Miller, K. S., Grasperge, B., Sullivan, S., Chaffin, A. E., & Bunnell, B. A. (2020). Acellular Biologic Nipple–Areolar Complex Graft: In Vivo Murine and Nonhuman Primate Host Response Evaluation. Tissue Engineering Part A, 26(15–16), 872–885. https://doi.org/10.1089/ten.tea.2019.0222

Stem Cells and Development / Oct 01, 2022

Hamel, K. M., Liimatta, K. Q., Belgodere, J. A., Bunnell, B. A., Gimble, J. M., & Martin, E. C. (2022). Adipose-Derived Stromal/Stem Cell Response to Tumors and Wounds: Evaluation of Patient Age. Stem Cells and Development, 31(19–20), 579–592. https://doi.org/10.1089/scd.2021.0280

Journal of Visualized Experiments / Apr 23, 2021

Brown, L. M., Hebert, K. L., Gurrala, R. R., Byrne, C. E., Burow, M., Martin, E. C., & Lau, F. H. (2021). Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System. Journal of Visualized Experiments, 170. https://doi.org/10.3791/62009

Stem Cells and Development / Oct 01, 2022

Hamel, K. M., King, C. T., Cavalier, M. B., Liimatta, K. Q., Rozanski, G. L., King, T. A., Lam, M., Bingham, G. C., Byrne, C. E., Xing, D., Collins-Burow, B. M., Burow, M. E., Belgodere, J. A., Bratton, M. R., Bunnell, B. A., & Martin, E. C. (2022). Breast Cancer-Stromal Interactions: Adipose-Derived Stromal/Stem Cell Age and Cancer Subtype Mediated Remodeling. Stem Cells and Development, 31(19–20), 604–620. https://doi.org/10.1089/scd.2021.0279

Stem Cells and Development / Mar 01, 2021

Shaik, S., Martin, E., Hayes, D., Gimble, J., & Devireddy, R. (2021). microRNA Sequencing of CD34+ Sorted Adipose Stem Cells Undergoing Endotheliogenesis. Stem Cells and Development, 30(5), 265–288. https://doi.org/10.1089/scd.2020.0173

Stem Cells and Development / Dec 01, 2021

Zanata, F., Curley, L., Martin, E., Bowles, A., Bunnell, B. A., Wu, X., Ferreira, L. M., & Gimble, J. M. (2021). Comparative Analysis of Human Adipose-Derived Stromal/Stem Cells and Dermal Fibroblasts. Stem Cells and Development, 30(23), 1171–1178. https://doi.org/10.1089/scd.2021.0164

Tissue Engineering Part A / Apr 01, 2021

Frazier, T., Williams, C., Henderson, M., Duplessis, T., Rogers, E., Wu, X., Hamel, K., Martin, E. C., Mohiuddin, O., Shaik, S., Devireddy, R., Rowan, B. G., Hayes, D. J., & Gimble, J. M. (2021). Breast Cancer Reconstruction: Design Criteria for a Humanized Microphysiological System. Tissue Engineering Part A, 27(7–8), 479–488. https://doi.org/10.1089/ten.tea.2020.0372

Regenerative Medicine - from Protocol to Patient / Jan 01, 2016

Li, J., Martin, E. C., & Gimble, J. M. (2016). Adipose-Derived Stem/Stromal Cells. In Regenerative Medicine - from Protocol to Patient (pp. 363–387). Springer International Publishing. https://doi.org/10.1007/978-3-319-27610-6_14

Pharmacological Research / Jun 01, 2023

Nguyen, K., Hebert, K., McConnell, E., Cullen, N., Cheng, T., Awoyode, S., Martin, E., Chen, W., Wu, T., Alahari, S. K., Izadpanah, R., Collins-Burow, B. M., Lee, S. B., Drewry, D. H., & Burow, M. E. (2023). LKB1 signaling and patient survival outcomes in hepatocellular carcinoma. Pharmacological Research, 192, 106757. https://doi.org/10.1016/j.phrs.2023.106757

Frontiers in Molecular Biosciences / Jun 08, 2022

King, C. T., Matossian, M. D., Savoie, J. J., Nguyen, K., Wright, M. K., Byrne, C. E., Elliott, S., Burks, H. E., Bratton, M. R., Pashos, N. C., Bunnell, B. A., Burow, M. E., Collins-Burow, B. M., & Martin, E. C. (2022). Liver Kinase B1 Regulates Remodeling of the Tumor Microenvironment in Triple-Negative Breast Cancer. Frontiers in Molecular Biosciences, 9. https://doi.org/10.3389/fmolb.2022.847505

Oncology Letters / Mar 16, 2021

Matossian, M., Elliott, S., Rhodes, L., Martin, E., Hoang, V., Burks, H., Zuercher, W., Drewry, D., Collins‑Burow, B., & Burow, M. (2021). Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant‑resistant phenotype in breast cancer cells. Oncology Letters, 21(5). https://doi.org/10.3892/ol.2021.12641

Journal of Proteomics / Aug 01, 2020

Hoover, M. E., Martin, E. C., Llamas, C. B., Qureshi, A., Davis, T. A., Gimble, J. M., & Freitas, M. A. (2020). Proteomic characterization of a trauma-based rat model of heterotopic ossification identifies interactive signaling networks as potential therapeutic targets. Journal of Proteomics, 226, 103907. https://doi.org/10.1016/j.jprot.2020.103907

The FASEB Journal / Apr 01, 2019

Bratton, M., Byrne, C. E., Rahman, S. M., King, C. T., Copeland, C. E., Rhodes, L., Glotser, E., Ma, P., Skripnikova, E., Wiese, T., Melvin, A., & Martin, E. (2019). Using an in vitro fluidics approach to model the evolution of metastatic breast cancer reveals shear stress as a possible driver of genomic instability and somatic mutation. The FASEB Journal, 33(S1). Portico. https://doi.org/10.1096/fasebj.2019.33.1_supplement.lb175

Cytotherapy / May 01, 2018

Hamel, K. M., Gimble, J., Jung, J. P., & Martin, E. C. (2018). Age-dependent modulation of the extracellular microenvironment of human adipose-derived stem cells. Cytotherapy, 20(5), S85. https://doi.org/10.1016/j.jcyt.2018.02.241

Cancer Research / Mar 22, 2024

Martin, E., Benz, M., Hebert, K., Byrne, E., & Lau, F. (2024). Abstract 3906: Ex vivo breast tumors for understanding the patient specific tumor microenvironment remodeling and drug responses. Cancer Research, 84(6_Supplement), 3906–3906. https://doi.org/10.1158/1538-7445.am2024-3906

Microsystems & Nanoengineering / Feb 16, 2024

Ortega Quesada, B. A., Cuccia, J., Coates, R., Nassar, B., Littlefield, E., Martin, E. C., & Melvin, A. T. (2024). A modular microfluidic platform to study how fluid shear stress alters estrogen receptor phenotype in ER+ breast cancer cells. Microsystems & Nanoengineering, 10(1). https://doi.org/10.1038/s41378-024-00653-0

International Journal of Molecular Sciences / Sep 01, 2023

Al-Ghadban, S., Walczak, S. G., Isern, S. U., Martin, E. C., Herbst, K. L., & Bunnell, B. A. (2023). Enhanced Angiogenesis in HUVECs Preconditioned with Media from Adipocytes Differentiated from Lipedema Adipose Stem Cells In Vitro. International Journal of Molecular Sciences, 24(17), 13572. https://doi.org/10.3390/ijms241713572

Oct 10, 2023

Melvin, A., Quesada, B. O., Cuccia, J., Coates, R., Nassar, B., Littlefield, E., & Martin, E. (2023). A modular microfluidic platform to study how fluid shear stress alters estrogen receptor phenotype in ER+ breast cancer cells. https://doi.org/10.21203/rs.3.rs-3399118/v1

Methods in Molecular Biology / Jan 01, 2022

Rahman, S. M., Martin, E. C., & Melvin, A. T. (2022). Co-culture of Two Different Cell Lines in a Two-Layer Microfluidic Device. In Cancer Drug Resistance (pp. 33–47). Springer US. https://doi.org/10.1007/978-1-0716-2513-2_3

Cancer Research / Jun 15, 2022

Lau, F. H., Byrne, C. E., Brown, L., Fontenot, J., Tiongco, R. P., Gurrala, R. R., Cuccia, J., DiNardo, A., Burow, M., & Martin, E. C. (2022). Abstract 282: Breast cancer microphysiological systems based on human breast tissue. Cancer Research, 82(12_Supplement), 282–282. https://doi.org/10.1158/1538-7445.am2022-282

Cancer Research / Jun 15, 2022

Wright, M., Nguyen, K., Martin, E., Bratton, M., Collins-Burow, B., & Burow, M. (2022). Abstract 3831: Utilizing decellularized triple-negative breast cancer patient-derived tumor models as drug testing platforms. Cancer Research, 82(12_Supplement), 3831–3831. https://doi.org/10.1158/1538-7445.am2022-3831

Journal of Clinical and Translational Science / Apr 01, 2022

Hebert, K. L., Nguyen, K., Cheng, T., Alzoubi, M., Elliott, S., Collins-Burow, B., Martin, E., Lau, F., & Burow, M. (2022). 235 Analysiss of TNBC Cell Lines Cultured a Novel Translational Breast Cancer Microphysiological System (BC-MPS). Journal of Clinical and Translational Science, 6(s1), 37–37. https://doi.org/10.1017/cts.2022.124

Cancer Research / Feb 15, 2022

Hebert, K., Nguyen, K., Cheng, T., Alzoubi, M., Collins-Burow, B., Martin, E., Lau, F., & Burow, M. (2022). Abstract P5-02-03: Phenotypic analysis for TNBC using a novel breast cancer microphysiological system. Cancer Research, 82(4_Supplement), P5-02-03-P5-02–03. https://doi.org/10.1158/1538-7445.sabcs21-p5-02-03

Cancer Research / Feb 15, 2020

Wright, M., Matossian, M., King, C., Nguyen, K., Elliott, S., Alzoubi, M., Martin, E., Collins-Burow, B., & Burow, M. (2020). Abstract P3-01-16: Utilizing a decellularized patient-derived xenograft tumor model for the evaluation of triple negative breast cancer. Cancer Research, 80(4_Supplement), P3-01-16-P3-01–16. https://doi.org/10.1158/1538-7445.sabcs19-p3-01-16

Mar 08, 2021

Commonwealth Bank - Head Office cnr Pitt Street & Martin Place - Construction - View from Martin Place (Street level) - 18 April 1916 (plate 630). (2021). Reserve Bank of Australia. https://doi.org/10.47688/rba_archives_pn-000794

Cancer Research / Jul 01, 2021

Wright, M., Matossian, M., Alzoubi, M., King, C., Elliott, S., Bratton, M., Martin, E., Collins-Burow, B., & Burow, M. (2021). Abstract 80: Utilizing a decellularized PDX tumor matrix model to investigate LKB1 regulation of ECM remodeling in TNBC. Cancer Research, 81(13_Supplement), 80–80. https://doi.org/10.1158/1538-7445.am2021-80

PLOS ONE / Apr 29, 2021

Chang, T. C., Matossian, M. D., Elliott, S., Burks, H. E., Sabol, R. A., Ucar, D. A., Wathieu, H., Zabaleta, J., Valle, L. D., Gill, S., Martin, E., Riker, A. I., Miele, L., Bunnell, B. A., Burow, M. E., & Collins-Burow, B. M. (2021). Correction: Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor. PLOS ONE, 16(4), e0251106. https://doi.org/10.1371/journal.pone.0251106

Cancer Epidemiology, Biomarkers & Prevention / Jun 01, 2020

Matossian, M. D., Elliott, S., Burks, H. E., Wright, M., Sabol, R. A., Hoang, V. T., Ucar, D. A., Alfortish, A., Zabaleta, J., Hossain, F., Chang, T., Wathieu, H., Pashos, N., Bunnell, B., Moroz, K., Zea, A., Riker, A., Jones, S. D., Martin, E. C., … Burow, M. E. (2020). Abstract C110: Applications of patient-derived triple-negative breast cancer xenografts that represent understudied patients in Louisiana in targeted therapeutic research. Cancer Epidemiology, Biomarkers & Prevention, 29(6_Supplement_1), C110–C110. https://doi.org/10.1158/1538-7755.disp18-c110

Cancer Research / Feb 15, 2020

Matossian, M., Elliott, S., Wright, M., Chang, T., Alzoubi, M., Wathieu, H., Sabol, R., Alfortish, A., Burks, H., Hoang, V., Ucar, D., Windsor, G., Yan, T., Zabaleta, J., Hossain, F., Bunnell, B., Moroz, K., Zea, A., Riker, A., … Burow, M. (2020). Abstract P6-03-17: Effect of histone deacetylase inhibitors on patient-derived neoadjuvant chemotherapy resistant triple negative breast cancer xenografts that represent understudied patients. Cancer Research, 80(4_Supplement), P6-03-17-P6-03–17. https://doi.org/10.1158/1538-7445.sabcs19-p6-03-17

Molecular Cancer Therapeutics / Dec 01, 2019

Byrne, E., Astete, C. E., Vaithiyanathan, M., Melvin, A. T., Moradipour, M., Rankin, S. E., Knutson, B. L., Martin, E. C., & Sabliov, C. (2019). Abstract A105: Novel lignin-conjugated PLGA drug delivery system improves efficacy of MEK1/2 inhibitor in triple negative breast cancer. Molecular Cancer Therapeutics, 18(12_Supplement), A105–A105. https://doi.org/10.1158/1535-7163.targ-19-a105

Scilight / Aug 29, 2019

Mandel, S. (2019). Adaptable microfluidic device improves the measurement of cancer cell migration and trapping. Scilight, 2019(35). https://doi.org/10.1063/1.5123602

Cancer Research / Jul 01, 2019

Yan, T. J., Burow, M. E., & Martin, E. C. (2019). Abstract 4236: Evaluating alterations in mRNA biogenesis with TCGA breast cancer sequencing data. Cancer Research, 79(13_Supplement), 4236–4236. https://doi.org/10.1158/1538-7445.am2019-4236

Cancer Research / Aug 15, 2020

Hall, S. E., Lau, A., Dean, E., Martin, E., Ottley, C., Drew, Y., & Veal, G. (2020). Abstract 1385: In vitro evaluation of platinum chemotherapy combinations with the ATR inhibitor, ceralasertib (AZD6738). Cancer Research, 80(16_Supplement), 1385–1385. https://doi.org/10.1158/1538-7445.am2020-1385

Molecular Cancer Research / Aug 01, 2018

Matossian, M., Burks, H., Chang, T., Bowles, A., Sabol, R., Hoang, V., Bunnell, B., Alfortish, A., Moroz, K., Zea, A., Riker, A., Jones, S., Bilyeu, A. D. U., Hossain, F., Miller, K., Martin, E., O’Donnell, B., Pashos, N., Miele, L., … Collins-Burow, B. (2018). Abstract A01: Application of patient-derived models from understudied patient populations to discover therapeutically targetable pathways in triple-negative breast cancer systems. Molecular Cancer Research, 16(8_Supplement), A01–A01. https://doi.org/10.1158/1557-3125.advbc17-a01

Cancer Research / Jul 15, 2016

Burks, H. E., Rhodes, L. V., Martin, E. C., Hoang, V. T., Elliott, S., Badoo, M., Phamduy, T., Buechlein, A., Rusch, D., Chrisey, D., Flemington, E., Nephew, K., Collins-Burow, B., & Burow, M. E. (2016). Abstract 4410: ZEB2 drives cell motility and metastasis in ER+ breast cancer cells through a novel, E-cadherin independent pathway. Cancer Research, 76(14_Supplement), 4410–4410. https://doi.org/10.1158/1538-7445.am2016-4410

Cancer Research / Jul 15, 2016

Hoang, V. T., Elliott, S., Martin, E. C., Rhodes, L. V., Burks, H. E., Matossian, M., Chakrabarty, S., Monlish, D., Phamduy, T. B., Curley, L., Anbalagan, M., Rowan, B. G., Chrisey, D., Cavanaugh, J. E., Flaherty, P. T., Collins-Burow, B. M., & Burow, M. E. (2016). Abstract 1596: Induction of mesenchymal-to-epithelial transition through pan-MEK inhibition in triple-negative breast cancer. Cancer Research, 76(14_Supplement), 1596–1596. https://doi.org/10.1158/1538-7445.am2016-1596

Cancer Research / Jul 15, 2016

Martin, E., Pashos, N., Gimble, J., Bunnell, B., Burow, M., & Collins-Burow, B. (2016). Abstract 5096: Development of a decellularized tumor model for the evaluation of breast carcinomas. Cancer Research, 76(14_Supplement), 5096–5096. https://doi.org/10.1158/1538-7445.am2016-5096

Cancer Research / Oct 01, 2014

Rhodes, L. V., Tate, C. R., Burks, H. E., Hoang, V. T., Gilliam, D., Martin, E. C., Elliott, S., Miller, D. F., Buechlein, A., Rusch, D., Tang, H., Nephew, K. P., Burow, M. E., & Collins-Burow, B. M. (2014). Abstract 1571: The tumor suppressor Liver Kinase B1 inhibits triple-negative breast cancer cell metastasis via regulation of AP-1 signaling. Cancer Research, 74(19_Supplement), 1571–1571. https://doi.org/10.1158/1538-7445.am2014-1571

Cancer Research / Oct 01, 2014

Hoang, V. T., Elliott, S., Martin, E. C., Rhodes, L. V., Segar, H. C., Burks, H., Chakrabarty, S., Monlish, D., Phamduy, T. B., Chrisey, D., Cavanaugh, J. E., Flaherty, P., Collins-Burow, B. M., & Burow, M. E. (2014). Abstract 1052: Dual role of MEK1/2 and MEK5 in the reversal of epithelial-to-mesenchymal transition. Cancer Research, 74(19_Supplement), 1052–1052. https://doi.org/10.1158/1538-7445.am2014-1052

Cancer Research / Oct 01, 2014

Burks, H. E., Rhodes, L., Martin, E., Phamduy, T., Elliot, S., Hoang, V., Segar, H., Buechlein, A., Rusch, D., Miller, D., Baddoo, M., Flemington, E., Nephew, K., Chrisey, D., Collins-Burow, B., & Burow, M. (2014). Abstract 1034: ZEB2 promotes cell motility and metastasis in ER+ breast cancer cells. Cancer Research, 74(19_Supplement), 1034–1034. https://doi.org/10.1158/1538-7445.am2014-1034

Jul 01, 2013

Clements, J. D. (2013). Tulane/Xavier Vaccine Peptide Program. Defense Technical Information Center. https://doi.org/10.21236/ada615102